Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
SoSe 2025
- Klinische Visite neuroendokrine Tumoren
- Blockpraktikum Innere Medizin (PV)
- Pathophysiologie (WA)
- Wahlfach Klinische Endokrinologie und Diabetologie
- Kolloquium Endokrinologie und Stoffwechsel (*)
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
- Neurochirurgisch-endokrinologische Konferenz / Endokrines Tumorzentrum am WTZ
- Differentialdiagnose Innere Krankheiten
- Klinische Visite Endokrinologie und Stoffwechsel
- Innere Medizin für Studierende im Praktischen Jahr (*)
- Seminare für Doktoranden in der Endokrinologie und Diabetologie
- Wiss. Arbeiten, Klinik für Endokrinologie, Diabetologie und Stoffwechsel
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
- Neurochirurgisch-endokrinologische Konferenz / Endokrines Tumorzentrum am WTZ
- Pathophysiologie (WA)
- Kolloquium Endokrinologie und Stoffwechsel (*)
- Wahlfach Klinische Endokrinologie und Diabetologie
- Blockpraktikum Innere Medizin (PV)
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
- Seminare für Doktoranden in der Endokrinologie und Diabetologie
- Innere Medizin für Studierende im Praktischen Jahr (*)
- Differentialdiagnose Innere Krankheiten
- Klinische Visite neuroendokrine Tumoren
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
The Coronary Artery Calcium Score as Prognostic Tool for Cardiovascular Events in Patients with Cushing’s SyndromeIn: Hormone and Metabolic Research , Jg. 57 2025, Nr. 04, S. 229 – 235
-
Transition bei komplexen endokrinologischen und diabetologischen ErkrankungenIn: Die Innere Medizin 2025 , in press
-
Transition bei komplexen endokrinologischen und diabetologischen Erkrankungen Transition in cases of complex endocrine and diabetic diseasesIn: Monatsschrift Kinderheilkunde 2025 , in press
-
Exploring potential influencing factors of inadherence to specialist aftercare and long-term medication in patients with acromegalyIn: Pituitary , Jg. 27 2024, Nr. 4, S. 403 – 415DOI (Open Access)
-
Hormonal Hypersecretion and Pain : Rare But Not To Be ForgottenIn: The American Journal of Medicine , Jg. 137 2024, Nr. 4, S. 311 – 314
-
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approachIn: Pituitary , Jg. 27 2024, Nr. 5, S. 545 – 554DOI (Open Access)
-
The effect of coping strategies on health–related quality of life in acromegaly patientsIn: Endocrine , Jg. 84 2024, Nr. 3, S. 1108 – 1115DOI (Open Access)
-
Transition from Paediatric to Adult Care in CAH : 20 Years of Experience at a Tertiary Referral CenterIn: Hormone and Metabolic Research , Jg. 56 2024, Nr. 1, S. 45 – 50
-
Venous thromboembolism in Cushing syndrome : Results from an EuRRECa and Endo-ERN surveyIn: Endocrine Connections , Jg. 13 2024, Nr. 6, e240046DOI (Open Access)
-
Efficacy and Safety of¹²⁴I-MIBG Dosimetry-Guided High-Activity¹³¹I-MIBG Therapy of Advanced Pheochromocytoma or NeuroblastomaIn: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 6, S. 885 – 891DOI (Open Access)
-
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion : know the condition and do not mistake for adenomaIn: Pituitary , Jg. 26 2023, Nr. 1, S. 164 – 170DOI (Open Access)
-
Pre-Surgery Patient Health Contributes to Aggravated Sino-Nasal Outcome and Quality of Life after Pituitary AdenomectomyIn: Medicina , Jg. 59 2023, Nr. 1, 127DOI, Online Volltext (Open Access)
-
Clonidine suppression test for a reliable diagnosis of pheochromocytoma : When to useIn: Clinical Endocrinology , Jg. 97 2022, Nr. 5, S. 541 – 550DOI (Open Access)
-
Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with PheochromocytomaIn: Journal of Nuclear Medicine (JNM) , Jg. 63 2022, Nr. 6, S. 869 – 874DOI (Open Access)
-
Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in EuropeIn: European Journal of Endocrinology (EJE) , Jg. 186 2022, Nr. 5, S. K17 – K24DOI (Open Access)
-
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyIn: Endocrine , Jg. 75 2022, Nr. 1, S. 293 – 302DOI (Open Access)
-
Adults’ Adherence to Growth Hormone Replacement in Relation to Medication-Related Beliefs, Coping and Quality of Life : An Exploratory AnalysisIn: Frontiers in Endocrinology , Jg. 12 2021, 680964DOI, Online Volltext (Open Access)
-
Distinct Late-Night Salivary Cortisol Cut-Off Values for the Diagnosis of HypercortisolismIn: Hormone and Metabolic Research , Jg. 53 2021, Nr. 10, S. 662 – 671DOI (Open Access)
-
Illness-related burden, personal resources and need for support in patients with acromegaly : Results of a focus group analysisIn: Growth Hormone and IGF Research , Jg. 60-61 2021, 101422
-
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas -A German SurveyIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) , Jg. 105 2020, Nr. 3, S. e660 – e675DOI (Open Access)
-
Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism : The patients‘ perspectiveIn: Pituitary , Jg. 23 2020, Nr. 5, S. 479 – 487DOI (Open Access)
-
Neuroendokrine Neoplasien des VerdauungstraktsIn: Best Practice Onkologie , Jg. 15 2020, Nr. 7-8, S. 320 – 333
-
Phäochromozytomatose nach Adrenalektomie : Metastasierung oder Zellverschleppung?In: Der Chirurg , Jg. 91 2020, Nr. 4, S. 345 – 353
-
Prevalence of Osteopathologies in Children and Adolescents After Diagnosis of Acute Lymphoblastic LeukemiaIn: Frontiers in Pediatrics , Jg. 8 2020, 509DOI, Online Volltext (Open Access)
-
Erratum zu: Inzidentalome der Nebennieren : Diagnostisches und therapeutisches Konzept aus endokrinologischer SichtIn: Der Chirurg , Jg. 90 2019, Nr. 3, S. 235 – 235DOI (Open Access)
-
Inzidentalome der Nebennieren : Diagnostisches und therapeutisches Konzept aus endokrinologischer SichtIn: Der Chirurg , Jg. 90 2019, Nr. 1, S. 3 – 8
-
Resistance to GHRH but Not to PTH in a 15-year-old boy with pseudohypoparathyroidism 1AIn: Journal of the Endocrine Society , Jg. 3 2019, Nr. 7, S. 1383 – 1389DOI (Open Access)
-
Children, adolescents and young adults with PWS present with low-normal bone mineral content despite treatment with growth hormone during childhoodIn: Hormone Research in Paediatrics , Jg. 88 2017, Nr. Suppl. 1, S. 260 – 260
-
Genetische Ursachen bei endokrinen Erkrankungen am Beispiel endokriner TumorsyndromeIn: Deutsche Medizinische Wochenschrift - DMW , Jg. 142 2017, Nr. 9, S. 665 – 672
-
Loss of Functional Osteoprotegerin : More Than a Skeletal ProblemIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) , Jg. 102 2017, Nr. 1, S. 210 – 219
-
Loss of Functional Osteoprotegerin : More than a Skeletal ProblemIn: Hormone Research in Paediatrics , Jg. 86 2016, Nr. Suppl. 1, S. 523 – 523
-
Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of EverolimusIn: Targeted Oncology , Jg. 11 2016, Nr. 5, S. 667 – 675
-
Sunitinib Efficacy in Patients with Advanced pNET in Clinical PracticeIn: Hormone and Metabolic Research , Jg. 48 2016, Nr. 9, S. 575 – 580
-
Health-Related Quality-of-Life (HRQoL) in Patients (pts) with Advanced Neuroendocrine Tumors (NET) Treated with Everolimus (EVE) : Results from an Open-Label, Phase IIIb, Multicenter, Expanded Access Program (EAP)
11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 5-7, 2014,In: Neuroendocrinology , Jg. 99 2014, Nr. 3-4, S. 277 -
Safety and Quality-Of-Life (QOL) Assessments in the Open-Label, Multicenter, Phase 3b, Expanded Access Study of Everolimus in Patients with Advanced Neuroendocrine Tumors (NET)In: Pancreas , Jg. 43 2014, Nr. 3, S. 500 – 501
-
Streptozotocin-based chemotherapy in pNET : A single-centre experienceIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 122 2014, Nr. 3, S. P108
-
Malignant Prolactinoma - a therapeutic challengeIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 121 2013
-
Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET)In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 15, Suppl., S. 4138
-
Quality-of-life (QoL) assessments in patients (pts) with pancreatic neuroendocrine tumors (pNET) enrolled in the open-label, phase 3b, multicenter, expanded access study of everolimus in pts with advanced NETIn: European Journal of Cancer (EJC) , Jg. 49 2013, Nr. Suppl. 2, S. 619
-
User Profiles of a Smartphone Application to Support Drug Adherence - Experiences from the iNephro ProjectIn: PLoS ONE , Jg. 8 2013, Nr. 10, e78547DOI (Open Access)
-
Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissuesIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 120 2012, Nr. 8, S. 482 – 489
-
Effects of standard glucocorticoid replacement therapies on subjective well-being : A randomized, double-blind, crossover study in patients with secondary adrenal insufficiencyIn: European Journal of Endocrinology (EJE) , Jg. 167 2012, Nr. 5, S. 679 – 685
-
Pasireotide (SOM230), a Novel Multireceptor‐Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7‐Day Subcutaneous Infusion in Healthy Male VolunteersIn: Journal of Clinical Pharmacology , Jg. 52 2012, Nr. 7, S. 1017 – 1027
-
Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal massIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 120 2012, Nr. 8, S. 494 – 500
-
Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers : A Single-Center, Open-Label, Ascending-Dose StudyIn: Clinical Therapeutics , Jg. 34 2012, Nr. 3, S. 677 – 688
-
Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center ExperienceIn: Hormone and Metabolic Research , Jg. 43 2011, Nr. 12, S. 838 – 843
-
Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia : Utility of salivary 17α- hydroxyprogesterone day profilesIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 119 2011, Nr. 3, S. 131 – 138
-
Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine : a Single-Center ExperienceIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 119 2011, Nr. 9, S. 540 – 543
-
⁶⁸Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUV mₐₓIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 38 2011, Nr. 7, S. 1224 – 1236
-
Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasmaIn: Clinical Endocrinology , Jg. 73 2010, Nr. 2, S. 153 – 160
-
Randomized, Double-Blinded, Cross-Over Study Comparing Various Glucocorticoid Substitution Schemes in Secondary Adrenal Insufficiency
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine Reviews , Jg. 31 2010, Nr. Suppl. 1 -
Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research , Jg. 40 2008, Nr. 3, S. 181 – 188
-
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumoursIn: Clinical Endocrinology , Jg. 68 2008, Nr. 6, S. 850 – 857
-
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal massIn: European Journal of Endocrinology , Jg. 154 2006, Nr. 3, S. 409 – 417DOI (Open Access)
-
Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4, and 5 in various adrenal tumorsIn: Endocrine Research , Jg. 30 2004, Nr. 4, S. 931 – 934
-
A novel variant in PRKAR1A at the exon-intron border leads to aberrant splicing in patients affected by carney complex
61st Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 21–23, 2023, The Hague, The Netherlands,In: Hormone Research in Paediatrics , Jg. 96 2023, Nr. Suppl. 4, S. 449 – 450DOI (Open Access) -
Prognostic value of the post-treatment 177Lu-DOTATOC scintigraphy in NET patients undergoing PRRT
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 50 2023, Nr. 1 supplement, S. S134 -
Successful transition in Congenital Adrenal Hyperplasia : A single centre experience over 20 yearsIn: Hormone Research in Paediatrics , Jg. 96 2023, Nr. Suppl. 4, S. 147 – 148
-
Efficacy and safety of 124-I-MIBG guided high activity 131-I-MIBG therapy of metastatic pheochromocytoma and neuroblastomaIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 48 2021, Nr. Suppl. 1, S. 290 – S291
-
Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumors
Annual Congress of the European Association of Nuclear Medicine, EANM‘18, October 13 – 17, 2018, Düsseldorf, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 45 2018, Nr. Suppl. 1, S. S65 -
Pre-treatment intensity of DOTATOC uptake for prediction of response to selective intravascular radionuclide therapy
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 42 2015, Nr. Suppl. 1, S. S8 – S9 -
Chemotherapy in the Treatment of Progressive, Undifferentiated Neuroendocrine Carcinomas : A Single-Center Experience
7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease March 11–12, 2010 Berlin, Germany,In: Neuroendocrinology , Jg. 92 2010, Nr. 1, S. 27